Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

195 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Immunogenicity of a tetravalent meningococcal glycoconjugate vaccine in infants: a randomized controlled trial.
Snape MD, Perrett KP, Ford KJ, John TM, Pace D, Yu LM, Langley JM, McNeil S, Dull PM, Ceddia F, Anemona A, Halperin SA, Dobson S, Pollard AJ. Snape MD, et al. Among authors: langley jm. JAMA. 2008 Jan 9;299(2):173-84. doi: 10.1001/jama.2007.29-c. JAMA. 2008. PMID: 18182599 Clinical Trial.
Phase 1 first-in-human studies of the reactogenicity and immunogenicity of a recombinant meningococcal NspA vaccine in healthy adults.
Halperin SA, Langley JM, Smith B, Wunderli P, Kaufman L, Kimura A, Martin D. Halperin SA, et al. Among authors: langley jm. Vaccine. 2007 Jan 5;25(3):450-7. doi: 10.1016/j.vaccine.2006.08.001. Epub 2006 Aug 10. Vaccine. 2007. PMID: 17052819 Clinical Trial.
Influenza and the influenza vaccine.
MacDonald N, Weir E, Langley JM. MacDonald N, et al. Among authors: langley jm. CMAJ. 2007 Oct 23;177(9):1028. doi: 10.1503/cmaj.071290. CMAJ. 2007. PMID: 17954891 Free PMC article. No abstract available.
Immunogenicity and immune memory of a nonadjuvanted quadrivalent meningococcal glycoconjugate vaccine in infants.
Perrett KP, Snape MD, Ford KJ, John TM, Yu LM, Langley JM, McNeil S, Dull PM, Ceddia F, Anemona A, Halperin SA, Dobson S, Pollard AJ. Perrett KP, et al. Among authors: langley jm. Pediatr Infect Dis J. 2009 Mar;28(3):186-93. doi: 10.1097/INF.0b013e31818e037d. Pediatr Infect Dis J. 2009. PMID: 19209097 Clinical Trial.
Safety and cross-reactive immunogenicity of candidate AS03-adjuvanted prepandemic H5N1 influenza vaccines: a randomized controlled phase 1/2 trial in adults.
Langley JM, Frenette L, Ferguson L, Riff D, Sheldon E, Risi G, Johnson C, Li P, Kenney R, Innis B, Fries L. Langley JM, et al. J Infect Dis. 2010 Jun 1;201(11):1644-53. doi: 10.1086/652701. J Infect Dis. 2010. PMID: 20423222 Clinical Trial.
Evaluation of adjuvanted pandemic H1N1(2009) influenza vaccine after one and two doses in young children.
Scheifele DW, Ward BJ, Dionne M, Vanderkooi O, Langley JM, Dobson S, Li Y, Law B, Halperin SA; Public Health Agency of Canada/Canadian Institutes of Health Research Influenza Research Network (PCIRN) Rapid Trials Investigators. Scheifele DW, et al. Among authors: langley jm. Pediatr Infect Dis J. 2011 May;30(5):402-7. doi: 10.1097/INF.0b013e3182068f33. Pediatr Infect Dis J. 2011. PMID: 21178654
Safety and immunogenicity of 2 mixed primary infant immunization schedules of pentavalent diphtheria, tetanus, acellular pertussis, inactivated poliomyelitis, and Haemophilus influenzae Type B vaccines at 2, 4, and 6 months of age: a randomized controlled trial.
Langley JM, Halperin SA, Rubin E, White C, McNeil S, Mutch J, Mackinnon-Cameron D, Smith B. Langley JM, et al. Pediatr Infect Dis J. 2012 Feb;31(2):189-92. doi: 10.1097/INF.0b013e318242462a. Pediatr Infect Dis J. 2012. PMID: 22173143 Clinical Trial.
Persistence of the immune response at 5 years of age following infant immunisation with investigational quadrivalent MenACWY conjugate vaccine formulations.
Khatami A, Snape MD, Davis E, Layton H, John T, Yu LM, Dull PM, Gill CJ, Odrjlin T, Dobson S, Halperin SA, Langley JM, McNeil SA, Pollard AJ. Khatami A, et al. Among authors: langley jm. Vaccine. 2012 Apr 16;30(18):2831-8. doi: 10.1016/j.vaccine.2012.02.046. Epub 2012 Mar 3. Vaccine. 2012. PMID: 22394992
Immunogenicity of 2 doses of HPV vaccine in younger adolescents vs 3 doses in young women: a randomized clinical trial.
Dobson SR, McNeil S, Dionne M, Dawar M, Ogilvie G, Krajden M, Sauvageau C, Scheifele DW, Kollmann TR, Halperin SA, Langley JM, Bettinger JA, Singer J, Money D, Miller D, Naus M, Marra F, Young E. Dobson SR, et al. Among authors: langley jm. JAMA. 2013 May 1;309(17):1793-802. doi: 10.1001/jama.2013.1625. JAMA. 2013. PMID: 23632723 Clinical Trial.
Rapid surveillance for health events following a mass meningococcal B vaccine program in a university setting: A Canadian Immunization Research Network study.
Langley JM, MacDougall DM, Halperin BA, Swain A, Halperin SA, Top KA, McNeil SA, MacKinnon-Cameron D, Marty K, De Serres G, Dubé E, Bettinger JA. Langley JM, et al. Vaccine. 2016 Jul 25;34(34):4046-9. doi: 10.1016/j.vaccine.2016.06.025. Epub 2016 Jun 11. Vaccine. 2016. PMID: 27302338
195 results
Jump to page